Ann: US DoD Report Travelan Protects Against Shigella in Primates, page-6

My only concern with the DoD is that the only other bio I know of that worked with them seemed to have things happen incredibly slowly. (though I know a sample size of one is a bit risky to generalise on)

So while obviously I think this is a great result, it's also important that DoD seems to be not wasting any time trying to progress this.

If the DoD does take this up there should be a huge knock-on to domestic sales too. For me the inflection point with this company at the will come when travelan sells enough to fund routine operations (about 3x where it is now)